Symposium underscores READDI’s role in ‘marathon of preparedness’

September 28, 2023
At a recent a half-day symposium hosted by the Rapidly Emerging Antiviral Drug Development Initiative, a blockbuster roster of speakers said drugs that broadly target virus families are essential when defending against future outbreaks.

Cervical cancer screening doubles when under-screened women are mailed testing kits

May 11, 2023
UNC researchers found that mailing HPV self-collection tests and offering assistance to book in-clinic screening appointments to under-screened, low-income women improved cervical cancer screening nearly two-fold compared to scheduling assistance alone.

Second Gillings Pitch Competition generates student-led public health solutions

January 20, 2023
The Gillings School recently wrapped its second Pitch Competition, where eight teams of students and alumni participated in a head-to-head challenge, leveraging their knowledge to explore innovative ideas to improve public health.

UNC landmark study paves the way for universal obstetric ultrasound

April 7, 2022
Establishing accurate gestational age with ultrasound early in pregnancy is essential to delivering high-quality care. Yet, the high cost for equipment and the need for trained sonographers limits its use in low-resource settings. A new study introduces a novel opportunity to democratize obstetric ultrasound.

Cash effectively motivates people to get COVID-19 vaccines

March 4, 2022
Guaranteed cash payments are the most effective way to encourage people to get a COVID-19 vaccine, according to a new report co-authored by Dr. Noel Brewer in The Lancet Regional Health.

The pills to fight COVID-19

January 12, 2022
There are new weapons in the war against COVID-19: antiviral pills that fight the virus before it multiplies and causes major damage.

Building a better bassinet

November 9, 2021
Carolina faculty helped develop an innovative hospital bassinet that enables breastfeeding and chestfeeding, skin-to-skin contact, and mother-infant bonding while improving newborn safety.

Duke, UNC-Chapel Hill scientists identify new antibody for COVID-19 and variants

November 2, 2021
A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

Helping Durham get ‘Back on the Bull’ during COVID-19

May 24, 2021
In Durham, North Carolina — less than 15 miles from the University of North Carolina at Chapel Hill — a public health campaign called “Back on the Bull” has been supporting local businesses throughout the COVID-19 pandemic. The Gillings School became involved when the Mayor of Durham invited faculty members to manage a community health ambassador program with the goal of helping small businesses in Durham County reopen safely following lockdown.

CDC grant expands COVID-19 vaccination to doctor’s offices, targeting hard-to-reach populations

May 18, 2021
Researchers with the UNC Center for Health Promotion and Disease Prevention will use centers for Disease Control and Prevention (CDC) grant to help doctor's offices across North Carolina take a shot at COVID-19 vaccination.

1
2
3
4
5
7
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400